$2500 | Single User
$5000 | Site License
$7500 | Enterprise License

Acne Vulgaris Global Clinical Trials Review, H1, 2017 [Report Updated: 22-02-2017]

Published by Global Data: 22 Feb 2017 | 50228 | In Stock

Introduction

Acne Vulgaris Global Clinical Trials Review, H1, 2017

Summary

GlobalData's clinical trial report, “Acne Vulgaris Global Clinical Trials Review, H1, 2017" provides an overview of Acne Vulgaris clinical trials scenario. This report provides top line data relating to the clinical trials on Acne Vulgaris. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

* Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
for Acne Vulgaris Global Clinical Trials Review, H1, 2017 [Report Updated: 22-02-2017]

  • Table of Contents

    Table of Contents 2

    List of Tables 3

    List of Figures 3

    Report Guidance 4

    Clinical Trials by Region 5

    Clinical Trials and Average Enrollment by Country 6

    Top Five Countries Contributing to Clinical Trials in Asia-Pacific 8

    Top Five Countries Contributing to Clinical Trials in Europe 9

    Top Countries Contributing to Clinical Trials in North America 10

    Top Countries Contributing to Clinical Trials in Middle East and Africa 11

    Top Five Countries Contributing to Clinical Trials in Central and South America 12

    Clinical Trials by G7 Countries: Proportion of Acne Vulgaris to Dermatology Clinical Trials 13

    Clinical Trials by Phase in G7 Countries 14

    Clinical Trials in G7 Countries by Trial Status 15

    Clinical Trials by E7 Countries: Proportion of Acne Vulgaris to Dermatology Clinical Trials 16

    Clinical Trials by Phase in E7 Countries 17

    Clinical Trials in E7 Countries by Trial Status 18

    Clinical Trials by Phase 19

    In Progress Trials by Phase 20

    Clinical Trials by Trial Status 21

    Clinical Trials by End Point Status 22

    Subjects Recruited Over a Period of Time 23

    Clinical Trials by Sponsor Type 24

    Prominent Sponsors 25

    Top Companies Participating in Acne Vulgaris Therapeutics Clinical Trials 26

    Prominent Drugs 27

    Latest Clinical Trials News on Acne Vulgaris 28

    Feb 07, 2017: Vyome Announces Top-line Results from Phase 1 Study of VB-1953 for Patients with Facial Acne Vulgaris 28

    Jan 27, 2017: Novan Reports Topline Results from SB204 Phase 3 Pivotal Trials 28

    Jan 26, 2017: SPIE Photonics West Presentations to Show BioPharmX was First to Visualize Minocycline on the Skin Using Multiphoton Microscopy 29

    Jan 12, 2017: BioPharmX Data Suggest Anti-Inflammatory Activity of BPX-01 Topical Minocycline Gel 29

    Jan 04, 2017: BioPharmX Completes Enrollment of BPX-01 Phase 2b OPAL Clinical Trial for Acne Vulgaris 30

    Jan 03, 2017: Dermira Initiates Phase 3 Clinical Program in Acne 30

    Dec 01, 2016: BioPharmX Poster at ASCB Annual Meeting to Show Topical Minocycline Has Potential to Deliver Non-Antibiotic Benefits 31

    Nov 28, 2016: Foamix Announces Completion of Patient Enrollment in Phase 3 Acne Trials for Minocycline Foam FMX101 31

    Clinical Trial Profile Snapshots 32

    Appendix 324

    Abbreviations 324

    Definitions 324

    Research Methodology 325

    Secondary Research 325

    About GlobalData 326

    Contact Us 326

    Disclaimer 326

    Source 327

List Of Tables
in Acne Vulgaris Global Clinical Trials Review, H1, 2017 [Report Updated: 22-02-2017]

List of Tables

Acne Vulgaris Therapeutics, Global, Clinical Trials by Region, 2017* 5

Acne Vulgaris Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 6

Acne Vulgaris Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 7

Acne Vulgaris Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 8

Acne Vulgaris Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 9

Acne Vulgaris Therapeutics Clinical Trials, North America, Top Countries, 2017* 10

Acne Vulgaris Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 11

Acne Vulgaris Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 12

Proportion of Acne Vulgaris to Dermatology Clinical Trials, G7 Countries (%), 2017* 13

Acne Vulgaris Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 14

Acne Vulgaris Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 15

Proportion of Acne Vulgaris to Dermatology Clinical Trials, E7 Countries (%), 2017* 16

Acne Vulgaris Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 17

Acne Vulgaris Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 18

Acne Vulgaris Therapeutics, Global, Clinical Trials by Phase, 2017* 19

Acne Vulgaris Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 20

Acne Vulgaris Therapeutics, Global, Clinical Trials by Trial Status, 2017* 21

Acne Vulgaris Therapeutics Clinical Trials, Global, by End Point Status, 2017* 22

Acne Vulgaris Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 23

Acne Vulgaris Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 24

Acne Vulgaris Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 25

Acne Vulgaris Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 26

Acne Vulgaris Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 27

List Of Figures, Charts and Diagrams
in Acne Vulgaris Global Clinical Trials Review, H1, 2017 [Report Updated: 22-02-2017]

List of Figures

Acne Vulgaris Therapeutics, Global, Clinical Trials by Region (%), 2017* 5

Acne Vulgaris Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 6

Acne Vulgaris Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 7

Acne Vulgaris Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 8

Acne Vulgaris Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 9

Acne Vulgaris Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 10

Acne Vulgaris Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 11

Acne Vulgaris Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 12

Proportion of Acne Vulgaris to Dermatology Clinical Trials, G7 Countries (%), 2017* 13

Acne Vulgaris Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 14

Acne Vulgaris Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 15

Proportion of Acne Vulgaris to Dermatology Clinical Trials, E7 Countries (%), 2017* 16

Acne Vulgaris Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 17

Acne Vulgaris Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 18

Acne Vulgaris Therapeutics, Global, Clinical Trials by Phase (%), 2017* 19

Acne Vulgaris Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 20

Acne Vulgaris Therapeutics, Global, Clinical Trials by Trial Status, 2017* 21

Acne Vulgaris Therapeutics Clinical Trials, Global, by End Point Status, 2017* 22

Acne Vulgaris Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 23

Acne Vulgaris Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 24

Acne Vulgaris Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 25

Acne Vulgaris Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 26

Acne Vulgaris Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 27

GlobalData Methodology 325

Additional Details

Publisher

Global Data

Publisher Information

Reference

50228 | GDHC4067CTIDB

Number of Pages

324

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Acne Vulgaris Global Clinical Trials Review, H2, 2018
Acne Vulgaris Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, “Acn...
25 Oct 2018 by Global Data USD $2,500 More Info
Acne And Related Disorders Global Clinical Trials Review, H2, 2018
Acne And Related Disorders Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial...
25 Oct 2018 by Global Data USD $2,500 More Info
Global Acne Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Nov 2016 by Current Partnering USD $1,495 More Info
Global Acne Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Acne Vulgaris Global Clinical Trials Review, H2, 2016
Acne Vulgaris Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial report, “Acn...
27 Jul 2016 by Global Data USD $2,500 More Info
Acne Vulgaris Global Clinical Trials Review, H2, 2016
Acne Vulgaris Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial report, “Acn...
27 Jul 2016 by Global Data USD $2,500 More Info
Acne Vulgaris Global Clinical Trials Review, H1, 2016
Acne Vulgaris Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical trial report, “Acn...
15 Apr 2016 by Global Data USD $2,500 More Info
Acne Vulgaris Global Clinical Trials Review, H1, 2016
Acne Vulgaris Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical trial report, “Acn...
15 Apr 2016 by Global Data USD $2,500 More Info
Acne And Related Disorders Global Clinical Trials Review, H2, 2015
Acne And Related Disorders Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical trial...
30 Nov 2015 by Global Data USD $2,500 More Info
Global Acne Treatment Market: Trends and Opportunities (2014-2019)
Scope of the ReportThe report titled “Global Acne Treatment Market: Trends and Opportunities (2014-2...
01 Jan 2015 by Daedal Research USD $800 More Info

This report is published by Global Data

Download Free Report Summary PDF

Acne Vulgaris Global Clinical Trials Review, H1, 2017 [Report Updated: 22-02-2017] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data